Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Meyerozyma guilliermondii ATP-dependent RNA helicase DBP5 (DBP5) CSB-YP398506MTM
CSB-EP398506MTM
CSB-BP398506MTM
CSB-MP398506MTM
CSB-EP398506MTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Meyerozyma guilliermondii PAB-dependent poly (A)-specific ribonuclease subunit PAN3, partial CSB-YP398507MTM
CSB-EP398507MTM
CSB-BP398507MTM
CSB-MP398507MTM
CSB-EP398507MTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Meyerozyma guilliermondii ATP-dependent RNA helicase SUB2 (SUB2) CSB-YP398508MTM
CSB-EP398508MTM
CSB-BP398508MTM
CSB-MP398508MTM
CSB-EP398508MTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Meyerozyma guilliermondii Golgi apparatus membrane protein TVP18 (TVP18), partial CSB-YP398509MTM1
CSB-EP398509MTM1
CSB-BP398509MTM1
CSB-MP398509MTM1
CSB-EP398509MTM1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Meyerozyma guilliermondii Cap-associated protein CAF20 (CAF20) CSB-YP398510MTM
CSB-EP398510MTM
CSB-BP398510MTM
CSB-MP398510MTM
CSB-EP398510MTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Meyerozyma guilliermondii Actin cytoskeleton-regulatory complex protein END3 (END3) CSB-YP398511MTM
CSB-EP398511MTM
CSB-BP398511MTM
CSB-MP398511MTM
CSB-EP398511MTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Meyerozyma guilliermondii Maintenance of telomere capping protein 6 (MTC6), partial CSB-YP398512MTM
CSB-EP398512MTM
CSB-BP398512MTM
CSB-MP398512MTM
CSB-EP398512MTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Meyerozyma guilliermondii 54S ribosomal protein L4, mitochondrial (MRPL4) CSB-YP398513MTM
CSB-EP398513MTM
CSB-BP398513MTM
CSB-MP398513MTM
CSB-EP398513MTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Meyerozyma guilliermondii Sensitive to high expression protein 9 homolog, mitochondrial (SHE9), partial CSB-YP398514MTM1
CSB-EP398514MTM1
CSB-BP398514MTM1
CSB-MP398514MTM1
CSB-EP398514MTM1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Meyerozyma guilliermondii Signal peptidase complex catalytic subunit SEC11 (SEC11), partial CSB-YP398515MTM
CSB-EP398515MTM
CSB-BP398515MTM
CSB-MP398515MTM
CSB-EP398515MTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Meyerozyma guilliermondii Altered inheritance of mitochondria protein 32 (AIM32) CSB-YP398516MTM
CSB-EP398516MTM
CSB-BP398516MTM
CSB-MP398516MTM
CSB-EP398516MTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Meyerozyma guilliermondii Pre-rRNA-processing protein IPI1 (IPI1) CSB-YP398517MTM
CSB-EP398517MTM
CSB-BP398517MTM
CSB-MP398517MTM
CSB-EP398517MTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Meyerozyma guilliermondii Stress response regulator protein 1 (SRR1) CSB-YP398518MTM
CSB-EP398518MTM
CSB-BP398518MTM
CSB-MP398518MTM
CSB-EP398518MTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Meyerozyma guilliermondii Mitochondrial distribution and morphology protein 34 (MDM34), partial CSB-YP398519MTM
CSB-EP398519MTM
CSB-BP398519MTM
CSB-MP398519MTM
CSB-EP398519MTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Meyerozyma guilliermondii Pre-rRNA-processing protein RIX1 (RIX1), partial CSB-YP398520MTM
CSB-EP398520MTM
CSB-BP398520MTM
CSB-MP398520MTM
CSB-EP398520MTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Meyerozyma guilliermondii Polyadenylate-binding protein, cytoplasmic and nuclear (PAB1), partial CSB-YP398521MTM
CSB-EP398521MTM
CSB-BP398521MTM
CSB-MP398521MTM
CSB-EP398521MTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Meyerozyma guilliermondii Leukotriene A-4 hydrolase homolog 1 (PGUG_04447), partial CSB-YP398522MTM
CSB-EP398522MTM
CSB-BP398522MTM
CSB-MP398522MTM
CSB-EP398522MTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Meyerozyma guilliermondii Protein LOT5 (LOT5) CSB-YP398523MTM
CSB-EP398523MTM
CSB-BP398523MTM
CSB-MP398523MTM
CSB-EP398523MTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Meyerozyma guilliermondii Protein SDS23 (SDS23), partial CSB-YP398524MTM
CSB-EP398524MTM
CSB-BP398524MTM
CSB-MP398524MTM
CSB-EP398524MTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Meyerozyma guilliermondii Probable endonuclease LCL3 (LCL3), partial CSB-YP398525MTM1
CSB-EP398525MTM1
CSB-BP398525MTM1
CSB-MP398525MTM1
CSB-EP398525MTM1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>